Skip to main content

Advertisement

Table 1 Parameters used in the Joint Asia Diabetes Evaluation (JADE) electronic portal to derive the Care Management Level in Type 2 Diabetic Patients.

From: From design to implementation - The Joint Asia Diabetes Evaluation (JADE) program: A descriptive report of an electronic web-based diabetes management program

Derivation parameters Details
1. Clinically evident cardiovascular-renal complications History of stroke, coronary heart disease, non-fatal heart failure, peripheral vascular disease, end stage renal disease (dialysis or eGFR <15 ml/min/1.73 m2)
2. Risk stratification parameters Current or ex smoker BMI ≥ 27.5 kg/m2 or waist circumference ≥ 80 cm in women or ≥ 90 cm in men Blood pressure >130/80 mmHg or treatment with anti-hypertensive drugs LDL-C >2.5 mmol/l TG ≥ 2.3 mmol/l &/or HDL-C <1 mmol/l Treatment with lipid regulating drugs if LDL-C ≤ 2.5 mmol/l and TG <2.3 mmol/l and HDL-C ≥ 1.0 mmol/l Spot morning urine for ACR >3.5 mg/mmol in women or >2.5 mg/mmol in men Foot at risk defined by 2 of 3 of the following: sensory neuropathy, skin changes (e.g. fungal infection, dry skin) or deformities (e.g. claw feet or hallux deformities) Retinopathy HbA1c ≥ 8%
3. Hong Kong Diabetes Registry Risk Scores High sensitivity and specificity cutoff points for various clinical endpoints (stroke, coronary heart disease, end stage renal disease and heart failure)
4. Renal function eGFR by the MDRD equation
  1. eGFR, Estimated glomerular filtration rate; BMI, body mass index; LDL-C and HDL-C, low- and high-density lipoprotein cholesterol; TG, triglyceride; ACR, albumin creatinine ratio; HbA1c, glycated hemoglobin; MDRD, Modification of Diet for Renal Disease (ref. [40])